| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 06/02/2005 | WO2005049087A1 Remedy for chronic pelvic pain syndrome |
| 06/02/2005 | WO2005049023A1 Glyt1 transporter inhibitors |
| 06/02/2005 | WO2005049009A1 Methods and agents for inhibiting dynamin-dependent endocytosis |
| 06/02/2005 | WO2005023794A3 Compound libraries of 4-carboxamidopiperidine derivatives |
| 06/02/2005 | WO2005009961B1 Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions |
| 06/02/2005 | WO2004063150A3 Diagnostic and therapeutic alkyl piperidine/piperazine compounds and process |
| 06/02/2005 | WO2004039781A9 Platinum complexes |
| 06/02/2005 | WO2003075847A3 NOVEL CURCUMINOID-FACTOR VIIa CONSTRUCTS AS SUPPRESSORS OF TUMOR GROWTH AND ANGIOGENESIS |
| 06/02/2005 | US20050119332 Substituted thiophene compounds as modulators of protein tyrosine phosphatases (PTPases) |
| 06/02/2005 | US20050119256 Aromatic amino acid derivates and medicinal compositions |
| 06/02/2005 | US20050119252 Ligands of melanocortin receptors and compositions and methods related thereto |
| 06/02/2005 | US20050119250 Amino-derivatives as novel inhibitors of histone deacetylase |
| 06/02/2005 | US20050119245 Alpha -, beta -, and gamma -amino acid derivatives, e.g., S)-2-{N'-[4-(4-Fluoro-phenoxy)-phenyl]-N''-cyano-guanidino}-3-phenyl-N-(3-pyrrolidin-1-yl-propyl)-propionamide for the treatment of central nervous system conditions such as muscle spasticity, tinnitus, epilepsy and neuropathic pain. |
| 06/02/2005 | US20050119225 Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs |
| 06/02/2005 | US20050119157 Organic compounds |
| 06/02/2005 | US20050118619 Dark quenchers for fluorescence resonance energy transfer (FRET) in bioassays |
| 06/02/2005 | DE10123573B4 N-Oxidanthranylamid-Derivate und deren Verwendung als Arzneimittel N-Oxidanthranylamid derivatives and their use as medicaments |
| 06/02/2005 | CA2556801A1 Methods and agents for inhibiting dynamin-dependent endocytosis |
| 06/02/2005 | CA2545048A1 Androgen receptor modulators |
| 06/02/2005 | CA2543247A1 Benzannelated compounds as ppar activators |
| 06/01/2005 | EP1535919A2 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 06/01/2005 | EP1535909A2 Cyclic amine derivatives and their use as drugs |
| 06/01/2005 | EP1534693A2 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 06/01/2005 | EP1534689A1 Novel carboxamide compounds having an mch-antagonistic effect, medicaments containing said compounds, and methods for the production thereof |
| 06/01/2005 | EP1534680A1 Prenylation inhibitors and methods of their synthesis and use |
| 06/01/2005 | EP1534679A2 Inhibitors of post-amadori advanced glycation end products |
| 06/01/2005 | EP1534671A2 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 06/01/2005 | EP1534664A1 N-bisaryl- and n-aryl-cycloalkylidenyl-alpha-hydroxy-and alpha-alkoxy acid amides |
| 06/01/2005 | EP1534658A2 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 06/01/2005 | EP1534276A2 Non-nucleoside reverse transcriptase inhibitors |
| 06/01/2005 | EP1534273A2 Modulators of the glucocorticoid receptor and method |
| 06/01/2005 | EP1351959B1 Novel pleuromutilin derivatives |
| 06/01/2005 | EP1345902B1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same |
| 06/01/2005 | EP1254136A4 FACTOR Xa INHIBITORS WITH ARYL-AMIDINES AND DERIVATIVES, AND PRODRUGS THEREOF |
| 06/01/2005 | EP1115695B1 (r)-chiral halogenated 1-substitutedamino-(n+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity |
| 06/01/2005 | EP1114030B1 Pyridine ketones useful as herbicides |
| 06/01/2005 | EP1109965B1 Method of treating a textile |
| 06/01/2005 | EP1095015B1 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators |
| 06/01/2005 | EP0994862B1 Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation |
| 06/01/2005 | EP0993441B1 INHIBITORS OF p38 |
| 06/01/2005 | EP0946499B1 N-(aryl/heteroaryl/alkylacetyl) amino acid amides, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
| 06/01/2005 | EP0708756B1 Substituted 2-phenylpyridines with herbicidal action |
| 06/01/2005 | CN1622942A HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 06/01/2005 | CN1622832A Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque |
| 06/01/2005 | CN1204138C Pyrazolo [4, 3-d] pyrimidine derivs. |
| 06/01/2005 | CN1204137C Uracil compound and its appliance |
| 06/01/2005 | CN1203852C Valdecoxib compositions |
| 05/31/2005 | US6900345 Antibiotics; mutilin 14-[N-(2-carbamoyloxyethoxycarbonyl)]carbamate; therapy for bacteria infections; chemical synthesis |
| 05/31/2005 | US6900332 Converting alpha- isocyanoalkanoate esters in the presence of assistants at temperatures above 80 degrees C. into the 5-alkoxy-substituted oxazoles, and removing the reaction product from the reaction mixture |
| 05/31/2005 | US6900330 Process for producing 2,3-pyridinedicarboxylic acid |
| 05/31/2005 | US6900321 Substituted pyridyl amine complexes, and catalysts |
| 05/31/2005 | US6900319 Carbo- and heterocyclic amidines |
| 05/31/2005 | US6900244 Controlling lipid, cholesterol metabolism; anticholesterol agents |
| 05/31/2005 | US6900237 Sulfonamide compounds as protease inhibitors |
| 05/31/2005 | US6900232 For therapy of tumor metastasis, solid tumor growth (neoplasia), osteoporosis, Paget's disease, humoral hypercalcemia of malignancy, osteopenia, angiogenesis, including tumor angiogenesis and lymphangiogenesis |
| 05/31/2005 | US6900231 Aminopyridyl-substituted phenyl acetamides as protease inhibitors |
| 05/31/2005 | US6900218 Reducing oxidation stresses; central nervous system disorders; antiinflammatory agents |
| 05/31/2005 | US6900210 Pyridinyl, pyrimidinyl and pyrazinyl amides as potassium channel openers |
| 05/31/2005 | US6900202 Nicotinic acetylcholine receptor activators; treating neurodegenerative disorders |
| 05/31/2005 | US6900180 Mixture of folic acid, vitamin b6 and b12 with carbohydrates, fats and proteins; infant formula; sleep disorders |
| 05/31/2005 | US6899739 Hair dyes |
| 05/26/2005 | WO2005047256A1 The derivatives of pyridone and the use of them |
| 05/26/2005 | WO2005047255A1 Substituted nicotinoylcarbamates as pesticides |
| 05/26/2005 | WO2005047254A1 Octahydrophenanthrene hydrazinde derivatives useful as glucocorticoid receptor modulators |
| 05/26/2005 | WO2005047249A1 Benzylether amine compounds useful as ccr-5 antagonists |
| 05/26/2005 | WO2005047233A1 Novel herbicides |
| 05/26/2005 | WO2005047230A1 Bis-cationic compounds and use thereof |
| 05/26/2005 | WO2005046683A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 05/26/2005 | WO2005046604A2 Heteroaryl-hydrazone compounds |
| 05/26/2005 | WO2005046603A2 Pyridine compounds |
| 05/26/2005 | WO2005046599A2 Alpha, beta-unsaturated sulfoxides for treating proliferative disorders |
| 05/26/2005 | WO2004106363A3 A tag for purification of peptides |
| 05/26/2005 | WO2003054145A3 Dinuclear copper-based compound and ligand for nucleic acid scission and anticancer treatment |
| 05/26/2005 | US20050113595 C2-substituted idan-1-ols and their derivatives, processes for their preparation and their use as pharmaceuticals |
| 05/26/2005 | US20050113580 2-(3-{3-[[2-chloro-3-(trifluoromethyl)benzyl](2,2-dephenylethyl)amino]propoxy}phenyl)-ethanol; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and inhibiting cholesterol absorption |
| 05/26/2005 | US20050113578 Process for preparing substituted pyridines |
| 05/26/2005 | US20050113450 method of sterilization, sanitation, antisepsis, and disinfection, includes applying antimicrobial compounds to a surface; e.g. 2-[(3-{[4-chloro(methyl)anilino]sulfonyl}benzoyl)amino]-5-(trifluoromethyl)benzoic acid |
| 05/26/2005 | US20050113447 Selective retinoid agonists |
| 05/26/2005 | US20050113440 Compounds that modulate PPAR activity and methods for their preparation |
| 05/26/2005 | US20050113424 E.g., 4-{3-[4-(3-{4-[amino(imino)methyl]phenoxy}propyl)-1-piperazinyl]propoxy}benzamidine; an antifungal agent with good pharmacokinetics and excellent antifungal action; side effect reduction such as nephrotoxicity; action to Mycomycetes |
| 05/26/2005 | US20050113416 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 05/26/2005 | US20050113396 Na+/H++exchanger-3 (NHE-3) inhibitors; antiischemic agents |
| 05/26/2005 | US20050113373 medicine to inhibit proliferative conditions, such as cancer and psoriasis; detecting or identifying a histone deactylase (HDAC) in a biological sample |
| 05/26/2005 | US20050113366 Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of $g(g)-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses |
| 05/26/2005 | US20050113346 making sulfur compounds such as 2-((4-But-2-ynyloxy-benzenesulfonyl)-methyl-amino)-N-hydroxy-3-methyl -butyramide, used as tumor necrosis factor-alpha converting enzyme (TACE) inhibitors, for prophylaxis of rheumatic diseases, sepsis or inflammation |
| 05/26/2005 | US20050113344 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases |
| 05/26/2005 | US20050112407 Organic electroluminescent device |
| 05/26/2005 | CA2545259A1 Heteroaryl-hydrazone compounds |
| 05/26/2005 | CA2545258A1 Pyridine compounds |
| 05/26/2005 | CA2545020A1 Octahydrophenanthrene hydrazinde derivatives useful as glucocorticoid receptor modulators |
| 05/26/2005 | CA2543913A1 Benzylether amine compounds useful as ccr-5 antagonists |
| 05/26/2005 | CA2541949A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 05/25/2005 | EP1533303A1 Substituted Aminosalicylacid Amides ( intermediates ) |
| 05/25/2005 | EP1533294A1 Beta-alanine derivative and use thereof |
| 05/25/2005 | EP1533292A1 Dibenzylamine compound and medicinal use thereof |
| 05/25/2005 | EP1532310A1 Method for delivering biologically active substances |
| 05/25/2005 | EP1532209A2 Charge transport compositions and electronic devices made with such compositions |
| 05/25/2005 | EP1532158A1 Neutral metallic dendrimer complexes |
| 05/25/2005 | EP1532112A1 Process for the preparation of modification i of n-(1-methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridinesulfonamide |
| 05/25/2005 | EP1532111A1 2,5-disubstituted 3-mercaptopentanoic acid |